Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factor&#945; (adalimumab) in a Crohn's disease patient: case report and literature review.

Cesarini, Monica; Angelucci, Erika; Foglietta, Tiziana; Vernia, Piero

Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review.

Cesarini, Monica; Angelucci, Erika; Foglietta, Tiziana; Vernia, Piero.

Affiliation

Cesarini M; Gastroenterology Unit, "Sapienza" University of Rome, Rome, Italy.

J Crohns Colitis ; 5(6): 619-22, 2011 Dec.

Article in En | MEDLINE | ID: mdl-22115384

Subject(s)

Anti-Inflammatory Agents/adverse effects; Antibodies, Monoclonal, Humanized/adverse effects; Crohn Disease/drug therapy; Guillain-Barre Syndrome/chemically induced; Adalimumab; Aged; Anti-Inflammatory Agents/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Guillain-Barre Syndrome/drug therapy; Humans; Male; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Guillain-Barre Syndrome / Antibodies, Monoclonal, Humanized / Anti-Inflammatory Agents Limits: Aged / Humans / Male Language: En Journal: J Crohns Colitis Journal subject: GASTROENTEROLOGIA Year: 2011 Document type: Article Affiliation country: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google